Location History:
- Holland, MI (US) (2008)
- Portage, MI (US) (2010 - 2011)
Company Filing History:
Years Active: 2008-2011
Title: David Thomas Erdman: Innovator in Pharmaceutical Chemistry
Introduction
David Thomas Erdman is a notable inventor based in Portage, MI (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work primarily focuses on developing compounds that are useful in treating various diseases, including cancer.
Latest Patents
Erdman's latest patents include the invention of an isethionate salt of a selective CDK4 inhibitor. This invention discloses polymorphs of the isethionate salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one, which serves as a selective cyclin-dependent kinase 4 (CDK4) inhibitor. This compound is particularly useful for treating inflammation and cell proliferative diseases such as cancer and restenosis. Another significant patent involves the synthesis of 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones. This invention provides methods for preparing substituted 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones, which are beneficial in treating cell proliferative disorders.
Career Highlights
Throughout his career, Erdman has worked with prominent companies in the pharmaceutical industry, including Warner-Lambert Company and Pfizer Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Erdman has collaborated with notable professionals in his field, including Anthony Clyde Blackburn and Peter Laurence Toogood. These collaborations have likely enhanced his research and development efforts.
Conclusion
David Thomas Erdman is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations in treating serious health conditions. His contributions continue to impact the field positively.